Explore the words cloud of the PAPAstudy project. It provides you a very rough idea of what is the project "PAPAstudy" about.
The following table provides information about the project.
Coordinator |
UNIVERSITE DE PARIS
There are not information about this coordinator. Please contact Fabio for more information, thanks. |
Coordinator Country | France [FR] |
Project website | http://canaudlab.recherche.parisdescartes.fr/ |
Total cost | 1˙479˙260 € |
EC max contribution | 1˙479˙260 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2015-STG |
Funding Scheme | ERC-STG |
Starting year | 2016 |
Duration (year-month-day) | from 2016-03-01 to 2021-02-28 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITE DE PARIS | FR (PARIS) | coordinator | 1˙479˙260.00 |
2 | UNIVERSITE PARIS DESCARTES | FR (PARIS CEDEX 06) | coordinator | 0.00 |
My research project is focused on the biology of the podocyte during chronic kidney disease progression, one of the major public health challenges of the 21st Century. The podocyte is a highly specialized cell with foot processes expansion that function as vasculature-supporting cells, producing basement membrane components and a number of vascular growth factors. These cells play an essential role in renal physiology but their unique localization, as the primary filter, exposes them to many stresses in pathological conditions. In fact these cells are the direct target of many diseases such as diabetes or HIV. The molecular events and structural changes in podocyte during adaptation to nephron reduction are not well-characterized and efficient therapeutics dramatically lacking. In order to achieve the ultimate goal of improving care provided to patients suffering from renal failure, the dissection of the molecular pathways involved in podocyte adaptation and deterioration processes is mandatory. This project will combine complementary in vivo and in vitro approaches, experimental models of chronic kidney disease on genetically modified mice, as well as the use of a very innovative and new technology of bioengineering to explore the molecular and structural changes of the podocytes during kidney diseases. This work will be centralized on AKT2 and its partners, as we previously demonstrated its major role in podocyte adaptation to nephron reduction, but also on new players using unbiased approaches. In parallel and consistently with my previous works, we will systematically extend our findings to human through our unique Renal Biobank of Necker Hospital (Paris). The accomplishment of this project may lead to the discovery of novel therapeutic targets and strategies to slow down the progression of kidney disease.
year | authors and title | journal | last update |
---|---|---|---|
2016 |
M. Delville, E. Baye, A. Durrbach, V. Audard, T. Kofman, L. Braun, J. Olagne, C. Nguyen, G. Deschenes, B. Moulin, M. Delahousse, G. Kesler-Roussey, S. Beaudreuil, F. Martinez, M. Rabant, P. Grimbert, M. Gallazzini, F. Terzi, C. Legendre, G. Canaud B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS published pages: 2520-2527, ISSN: 1046-6673, DOI: 10.1681/ASN.2015091002 |
Journal of the American Society of Nephrology 27/8 | 2020-03-20 |
2016 |
Emilie Baye, Morgan Gallazzini, Marianne Delville, Christophe Legendre, Fabiola Terzi, Guillaume Canaud The costimulatory receptor B7-1 is not induced in injured podocytes published pages: 1037-1044, ISSN: 0085-2538, DOI: 10.1016/j.kint.2016.06.022 |
Kidney International 90/5 | 2020-03-20 |
2018 |
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, Laureline Berteloot, Sophia Ladraa, Jean-Paul Duong, Estelle Blanc, Simon C. Johnson, Clément Hoguin, Olivia Boccara, Sabine Sarnacki, Nathalie Boddaert, Stephanie Pannier, Frank Martinez, Sato Magassa, Junna Yamaguchi, Bertrand Knebelmann, Pierre Merville, Nicolas Grenier, Dominique Joly, Valérie Cormier-Daire, Caroline Michot, Christine Bole-Feysot, Arnaud Picard, Véronique Soupre, Stanislas Lyonnet, Jeremy Sadoine, Lotfi Slimani, Catherine Chaussain, Cécile Laroche-Raynaud, Laurent Guibaud, Christine Broissand, Jeanne Amiel, Christophe Legendre, Fabiola Terzi, Guillaume Canaud Targeted therapy in patients with PIK3CA-related overgrowth syndrome published pages: 540-546, ISSN: 0028-0836, DOI: 10.1038/s41586-018-0217-9 |
Nature 558/7711 | 2020-03-20 |
2019 |
Simon C. Johnson, Frank Martinez, Alessandro Bitto, Brenda Gonzalez, Cagdas Tazaerslan, Camille Cohen, Laure Delaval, José Timsit, Bertrand Knebelmann, Fabiola Terzi, Tarika Mahal, Yizhou Zhu, Philip G. Morgan, Margaret M. Sedensky, Matt Kaeberlein, Christophe Legendre, Yousin Suh, Guillaume Canaud mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases published pages: 455-466, ISSN: 0085-2538, DOI: 10.1016/j.kint.2018.08.038 |
Kidney International 95/2 | 2020-03-20 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PAPASTUDY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PAPASTUDY" are provided by the European Opendata Portal: CORDIS opendata.